ID: ALA594485

Max Phase: Preclinical

Molecular Formula: C21H12FNOS

Molecular Weight: 345.40

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  N#Cc1ccccc1-c1sc2ccccc2c1Oc1ccc(F)cc1

Standard InChI:  InChI=1S/C21H12FNOS/c22-15-9-11-16(12-10-15)24-20-18-7-3-4-8-19(18)25-21(20)17-6-2-1-5-14(17)13-23/h1-12H

Standard InChI Key:  ZACRLKWMPPKHTP-UHFFFAOYSA-N

Associated Targets(non-human)

Intestinal alkaline phosphatase 300 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 345.40Molecular Weight (Monoisotopic): 345.0624AlogP: 6.37#Rotatable Bonds: 3
Polar Surface Area: 33.02Molecular Species: NEUTRALHBA: 3HBD: 0
#RO5 Violations: 1HBA (Lipinski): 2HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 5.99CX LogD: 5.99
Aromatic Rings: 4Heavy Atoms: 25QED Weighted: 0.43Np Likeness Score: -1.33

References

1. Li L, Chang L, Pellet-Rostaing S, Liger F, Lemaire M, Buchet R, Wu Y..  (2009)  Synthesis and evaluation of benzo[b]thiophene derivatives as inhibitors of alkaline phosphatases.,  17  (20): [PMID:19781951] [10.1016/j.bmc.2009.08.048]

Source